Freeline Therapeutics Holdings plc (FRLN) Financials

NASDAQ Currency in USD Disclaimer

$6.49

north_east NA Past Year
Day's range
$6.48
Day's range
$6.49

FRLN Income statement / Annual

Last year (2022), Freeline Therapeutics Holdings plc's total revenue was $0.00, and the percentage change from the previous year is not available. In 2022, Freeline Therapeutics Holdings plc's net income was -$88.97 M. See Freeline Therapeutics Holdings plc,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $1.74 M $2.39 M $1.93 M $1.55 M $0.00
Gross Profit -$1.74 M -$2.39 M -$1.93 M -$1.55 M $0.00
Gross Profit Ratio 0 0 0 0 0
Research and Development Expenses $66.20 M $95.43 M $76.15 M $47.04 M $34.19 M
General & Administrative Expenses $30.66 M $44.57 M $26.30 M $16.60 M $6.79 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $30.66 M $44.57 M $26.30 M $16.60 M $6.79 M
Other Expenses -$1.57 M -$2.09 M -$15.27 M -$10.60 M -$390,000.00
Operating Expenses $95.29 M $137.91 M $87.18 M $53.05 M $32.72 M
Cost And Expenses $95.29 M $137.91 M $87.18 M $53.05 M $32.72 M
Interest Income $904,000.00 $403,951.00 $275,000.00 $74,306.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $151,000.00
Depreciation & Amortization $1.27 M $9.24 M $17.18 M $12.14 M $970,000.00
EBITDA -$97.17 M -$133.14 M -$85.27 M -$51.51 M -$32.14 M
EBITDA Ratio 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0
Total Other Income/Expenses Net $9.84 M $2.33 M $6.26 M $9.88 M -$470,797.00
Income Before Tax -$88.60 M -$140.05 M -$96.19 M -$53.77 M -$33.26 M
Income Before Tax Ratio 0 0 0 0 0
Income Tax Expense $368,000.00 $342,000.00 $129,000.00 $141,000.00 $27,000.00
Net Income -$88.97 M -$140.39 M -$96.32 M -$53.91 M -$33.28 M
Net Income Ratio 0 0 0 0 0
EPS -22.52 -58.98 -102.09 -127.39 -78.65
EPS Diluted -22.52 -58.98 -102.09 -127.39 -78.65
Weighted Average Shares Out $3.95 M $2.38 M $943,522.00 $423,188.00 $423,188.00
Weighted Average Shares Out Diluted $3.95 M $2.38 M $943,523.00 $423,188.00 $423,188.00
Link